The differential diagnosis of a TP53 genetic testing result.
作者信息
MacFarland Suzanne P, Maxwell Kara N
机构信息
Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
出版信息
Genet Med. 2018 Aug;20(8):806-808. doi: 10.1038/gim.2017.250. Epub 2018 Jan 11.
Abstract
摘要
相似文献
1
The differential diagnosis of a TP53 genetic testing result.TP53基因检测结果的鉴别诊断。
Genet Med. 2018 Aug;20(8):806-808. doi: 10.1038/gim.2017.250. Epub 2018 Jan 11.
2
Somatic TP53 variants frequently confound germ-line testing results.体细胞 TP53 变异常使种系检测结果产生混淆。
Genet Med. 2018 Aug;20(8):809-816. doi: 10.1038/gim.2017.196. Epub 2017 Nov 30.
3
Parent decision-making around the genetic testing of children for germline TP53 mutations.父母在对儿童进行种系 TP53 突变基因检测方面的决策。
Cancer. 2015 Jan 15;121(2):286-93. doi: 10.1002/cncr.29027. Epub 2014 Sep 15.
4
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.180 个疑似李-佛美尼综合征家族的 TP53 种系突变检测：不同家族表型中癌症的突变检出率和相对频率。
J Med Genet. 2010 Jun;47(6):421-8. doi: 10.1136/jmg.2009.073429.
5
Early onset HER2-positive breast cancer is associated with germline TP53 mutations.早期发病的 HER2 阳性乳腺癌与胚系 TP53 突变相关。
Cancer. 2012 Feb 15;118(4):908-13. doi: 10.1002/cncr.26377. Epub 2011 Jul 14.
6
TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort.胚系 TP53 基因突变检测在早发性乳腺癌中的应用：一项全国性队列研究的结果。
Fam Cancer. 2019 Apr;18(2):273-280. doi: 10.1007/s10689-018-00118-0.
7
Next generation sequencing is informing phenotype: a TP53 example.下一代测序技术正在为表型研究提供信息：以TP53为例。
Fam Cancer. 2018 Jan;17(1):123-128. doi: 10.1007/s10689-017-0002-1.
8
Clinical implications of germline mutations in breast cancer: TP53.乳腺癌种系突变的临床意义：TP53。
Breast Cancer Res Treat. 2018 Jan;167(2):417-423. doi: 10.1007/s10549-017-4531-y. Epub 2017 Oct 16.
9
Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing.基于面板检测的 TP53 基因突变携带者表型差异显现。
J Natl Cancer Inst. 2018 Aug 1;110(8):863-870. doi: 10.1093/jnci/djy001.
10
A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically.大量通过下一代测序遗传泛癌panel 检测到的貌似杂合性 TP53 致病性变异实际上是后天获得的体细胞突变。
Hum Mutat. 2020 Jan;41(1):203-211. doi: 10.1002/humu.23910. Epub 2019 Sep 23.
引用本文的文献
1
TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort.胚系 TP53 基因突变检测在早发性乳腺癌中的应用：一项全国性队列研究的结果。
Fam Cancer. 2019 Apr;18(2):273-280. doi: 10.1007/s10689-018-00118-0.
本文引用的文献
1
Somatic TP53 variants frequently confound germ-line testing results.体细胞 TP53 变异常使种系检测结果产生混淆。
Genet Med. 2018 Aug;20(8):809-816. doi: 10.1038/gim.2017.196. Epub 2017 Nov 30.
2
Contribution of de novo and mosaic mutations to Li-Fraumeni syndrome.新生突变和镶嵌突变对 Li-Fraumeni 综合征的贡献。
J Med Genet. 2018 Mar;55(3):173-180. doi: 10.1136/jmedgenet-2017-104976. Epub 2017 Oct 25.
3
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.与TET2缺陷相关的克隆性造血加速小鼠动脉粥样硬化发展。
Science. 2017 Feb 24;355(6327):842-847. doi: 10.1126/science.aag1381. Epub 2017 Jan 19.
4
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.NCCN 指南解读：遗传/家族性高风险评估：乳腺和卵巢，2017 年第 2 版。
J Natl Compr Canc Netw. 2017 Jan;15(1):9-20. doi: 10.6004/jnccn.2017.0003.
5
Mosaicism in health and disease - clones picking up speed.健康与疾病中的镶嵌现象——克隆正在加速。
Nat Rev Genet. 2017 Feb;18(2):128-142. doi: 10.1038/nrg.2016.145. Epub 2016 Dec 12.
6
Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma.卵巢癌女性血液中的 PPM1D 和 TP53 体细胞镶嵌突变。
JAMA Oncol. 2016 Mar;2(3):370-2. doi: 10.1001/jamaoncol.2015.6053.
7
Age-related clonal hematopoiesis associated with adverse outcomes.与不良预后相关的年龄相关性克隆性造血。
N Engl J Med. 2014 Dec 25;371(26):2488-98. doi: 10.1056/NEJMoa1408617. Epub 2014 Nov 26.
8
Age-related mutations associated with clonal hematopoietic expansion and malignancies.与克隆性造血扩张和恶性肿瘤相关的年龄相关突变。
Nat Med. 2014 Dec;20(12):1472-8. doi: 10.1038/nm.3733. Epub 2014 Oct 19.
9
Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.超越李-佛美尼综合征：携带p53种系突变家族的临床特征
J Clin Oncol. 2009 Mar 10;27(8):1250-6. doi: 10.1200/JCO.2008.16.6959. Epub 2009 Feb 9.
10
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.一种包含乳腺癌、肉瘤及其他肿瘤的家族综合征中的生殖系p53突变
Science. 1990 Nov 30;250(4985):1233-8. doi: 10.1126/science.1978757.
Zotero 插件